MIPS maintains top score in 2018 ERA rankings
The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.
The ERA process assesses the quality of research conducted at all Australian higher education institutions. The rankings provide an international benchmark by which to measure discipline expertise, and research quality and environment.
The Faculty has received the highest score of 5 in all its major disciplines: Medicinal and Biomolecular Chemistry, Nanotechnology, and Pharmacology and Pharmaceutical Sciences. The score of 5 denotes a research output that is well above world standard.
Professor Peter Scammells, Associate Dean Research said “the ERA results are very pleasing and a reflection of the Faculty’s commitment to maintaining quality and integrity of all our research programs”.
The latest rankings mean that MIPS has maintained the ranking it attained in 2015, having received 5 out of 5 in all four digit code disciplines, confirming its position as a world leader in its key research fields.
Monash University as a whole has improved in performance, receiving either a 4 or 5 in over 90% of submitted four digit disciplines. In all two digit disciplines, over 95% of codes received a 4 or 5.
“The ERA rankings are demonstrative of our passion for producing research that improves health outcomes and tackles real-world issues,” said Director of MIPS Professor Chris Porter.
“These figures strengthen our desire to generate research with impact and also to work harder to publish research of the highest quality.”